67-4

30/90

Figure 3　estimated change in uACR of each group. (L, M and H groups)Figure 4　estimated change in eGFR of each group. (L, M and H groups)sBP of less than 130 mmHg (13.1 mg/g・Cr/year) was significantly lower than those who had an sBP of more than 130 mmHg (230.9 mg/g・Cr/year) (p<0.001) (Figure 3). There was no significant change in ΔuACR between both sBP levels in Groups M and H. ΔeGFR/year in Group L patients with RASI (0.9mL/min/1.73m2) was significantly Comparison between groups in the estimated amount of change in uACR (mg/g・Cr) due to systolic blood pressure differences. uACR: mean ±SD. P<0.05 was consideration to be statistically significant (Mann-Whitney U-test). uACR had increased in patients with sBP of more than 130 mmHg in any of these groups, while significant difference was noted only in Group L.Comparison between groups in the estimated amount of change in eGFR (ml/min/1.73㎡) based on RASI administration. eGFR: mean ±SD. P<0.05 was consideration to be statistically significant (Mann-Whitney U-test).In patients with RASI, eGFR did not decrease only in patients included in Group L.350higher than in those without RASI (-2.0 mL/min/1.73m2) (p<0.001) (Figure 4). There was no significant change in ΔeGFR/year between patients treated with or without RASI in Groups M and H. In Group L, the levels of ΔuACR/year in the patients with an sBP of less than 130mmHg with or without RASI were lower than in those patients